Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.340
-0.030 (-8.11%)
Mar 28, 2024, 3:58 PM EDT - Market closed
Agile Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 5.25 | 19.14 | 14.46 | 34.48 | 7.85 | 35.95 | 48.75 | 34.4 | 40.18 | 2.12 | Upgrade
|
Short-Term Investments | 0 | 0 | 40.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 5.25 | 19.14 | 54.47 | 34.48 | 7.85 | 35.95 | 48.75 | 34.4 | 40.18 | 2.12 | Upgrade
|
Cash Growth | -72.60% | -64.86% | 57.98% | 339.17% | -78.16% | -26.25% | 41.74% | -14.40% | 1795.69% | -89.41% | Upgrade
|
Receivables | 3.38 | 1.53 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Inventory | 1.33 | 0.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 1.4 | 2.28 | 1.45 | 0.84 | 0.61 | 0.76 | 2.77 | 3.69 | 0.8 | 0.15 | Upgrade
|
Total Current Assets | 11.36 | 23.93 | 56.79 | 35.32 | 8.46 | 36.71 | 51.52 | 38.09 | 40.99 | 2.27 | Upgrade
|
Property, Plant & Equipment | 0.87 | 13.4 | 14.38 | 14.04 | 13.92 | 13.86 | 12.33 | 12.32 | 12.05 | 11.96 | Upgrade
|
Other Long-Term Assets | 2.01 | 2.01 | 1.9 | 0.18 | 0.02 | 0.02 | 0.02 | 0.31 | 1.79 | 0.18 | Upgrade
|
Total Long-Term Assets | 2.88 | 15.41 | 16.28 | 14.22 | 13.93 | 13.88 | 12.35 | 12.63 | 13.84 | 12.14 | Upgrade
|
Total Assets | 14.24 | 39.33 | 73.06 | 49.54 | 22.39 | 50.6 | 63.87 | 50.71 | 54.83 | 14.41 | Upgrade
|
Accounts Payable | 7.73 | 8.71 | 3.87 | 1.82 | 2.22 | 2.78 | 5.4 | 5.04 | 3.69 | 0.72 | Upgrade
|
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0.85 | 0 | 0 | 0 | 0.38 | Upgrade
|
Current Debt | 1.75 | 17.01 | 0.14 | 0.17 | 0 | 10.61 | 5.1 | 2.49 | 5 | 5.11 | Upgrade
|
Other Current Liabilities | 3.91 | 3.56 | 3.35 | 1.8 | 0 | 0.03 | 0.17 | 0.41 | 0.3 | 0.64 | Upgrade
|
Total Current Liabilities | 13.39 | 29.28 | 7.35 | 3.8 | 2.22 | 14.27 | 10.68 | 7.93 | 8.99 | 6.84 | Upgrade
|
Long-Term Debt | 0.47 | 0.78 | 16.38 | 0 | 0 | 0 | 10.9 | 13.04 | 9.83 | 9.77 | Upgrade
|
Other Long-Term Liabilities | 5.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69.23 | Upgrade
|
Total Long-Term Liabilities | 6.4 | 0.78 | 16.38 | 0 | 0 | 0 | 10.9 | 13.04 | 9.83 | 79 | Upgrade
|
Total Liabilities | 19.79 | 30.06 | 23.73 | 3.8 | 2.22 | 14.27 | 21.58 | 20.97 | 18.82 | 85.85 | Upgrade
|
Total Debt | 2.21 | 17.79 | 16.52 | 0.17 | 0 | 10.61 | 16 | 15.52 | 14.83 | 14.87 | Upgrade
|
Debt Growth | -87.57% | 7.71% | 9504.07% | - | - | -33.72% | 3.09% | 4.67% | -0.30% | 0.59% | Upgrade
|
Common Stock | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Retained Earnings | -408.7 | -387.12 | -312.22 | -260.37 | -241.55 | -221.77 | -193.47 | -164.73 | -134.39 | -118.31 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | -0.37 | -0.35 | -0.32 | -0.3 | -0.29 | -0.27 | Upgrade
|
Shareholders' Equity | -5.55 | 9.27 | 49.33 | 45.75 | 20.17 | 36.32 | 42.29 | 29.74 | 36.01 | -71.44 | Upgrade
|
Total Liabilities and Equity | 14.24 | 39.33 | 73.06 | 49.54 | 22.39 | 50.6 | 63.87 | 50.71 | 54.83 | 14.41 | Upgrade
|
Net Cash / Debt | 3.04 | 1.35 | 37.95 | 34.31 | 7.85 | 25.35 | 32.75 | 18.87 | 25.35 | -12.76 | Upgrade
|
Net Cash / Debt Growth | 124.65% | -96.44% | 10.62% | 336.98% | -69.02% | -22.60% | 73.52% | -25.56% | - | - | Upgrade
|
Net Cash Per Share | 0.00 | 3.13 | 781.94 | 810.25 | 317.65 | 1477.24 | 2116.81 | 1335.03 | 2302.96 | -2238.95 | Upgrade
|
Working Capital | - | -2.03 | -5.35 | 49.43 | 31.52 | 6.24 | 22.44 | 40.84 | 30.15 | 31.99 | Upgrade
|
Book Value Per Share | -0.00 | 21.52 | 1016.32 | 1080.39 | 816.23 | 2117.10 | 2733.61 | 2104.06 | 3270.89 | -12540.21 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.